heart disease

View All

Mobile Apps for Chronic Diseases Management
Assessing the Growing Role & the Demand of Apps in Managing the Chronic Diseases

Over the past few years, the prevalence of the chronic disease has grown significantly. The rising prevalence is leading to a severe social and economical burden on the individuals and their families. Chronic diseases are long-lasting conditions with endless side effects associated with them. Despite the rise in mo...

Find More

Pacemakers Pipeline Analysis
Continuous R&D Ramps Up the Pacemakers Pipeline Landscape, New Devices To Enter the Market Soon

Pacemaker is a device that is used to send small electrical impulses to the heart muscle to keep the heart rate regulated or to stimulate the lower chambers of the heart (ventricles). It can also be used to treat fainting spells (syncope), congestive heart failure, and hypertrophic cardiomyopathy. These are impl...

Find More

Precision-Medicine
Precision Medicine: An emerging approach to conventional treatment

As per WHO, “Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer”. The patients whose lives are afflicted with similar types of cancers have long been administered a similar type of treatment regimen b...

Find More

healthcare innovations
Top healthcare innovations changing the healthcare dynamics

William Blake, an English poet, painter, and printmaker, way back in 1803, said: "What is now proved was once only imagined.". The quote stays fit in today's highly innovative and technologically sophisticated society. Innovation has brought many life-saving products and services that have significantly improved th...

Find More

Cardiovascular Disease
Cardiovascular Disease: A major cause of health loss and a global burden

Cardiovascular diseases (CVDs) are one of the leading causes of death and health loss in people in the US. As per a study by the National Vital Statistics Report, every 37 seconds, one person dies of Cardiovascular diseases in the US.  Cardiovascular diseases also known as heart disease, encompasses a wide range...

Find More

SANOFI
Cholesterol drug Praluent successful in reducing heart risk

Sanofi and Regeneron Pharmaceuticals got effective results in reducing the risk of major adverse heart events in a clinical study of nearly 19,000 patients with the help of cholesterol drug Praluent. Drugmakers now hope that the results are good enough to convince insurers to pay for the pricey medicine. Treatment w...

Find More